课题基金 / 基金详情

CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION

CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION
内皮功能之间的心血管联系
批准号:
7376546
负责人:
Robert Daniel Brook
金额:
$2.1万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-05 至 2007-02-28

项目摘要

项目成果

Robert Daniel Brook的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Air pollution increases the risk for heart and vascular disease. This study is designed to improve our understanding of how air pollution effects blood vessels. Healthy, non-smoking adults, ages 18-50, of any gender, race or ethnicity, will be recruited to evaluate the impact of pollution on blood vessel function, blood pressure, and blood labs. Each subject will have their blood vessel function tested by an ultrasound and blood drawn before and immediately after breathing air that contains pollution concentrated from the natural atmosphere for 2 hours. The amount of pollution in the air is similar to that may be found in a busy city. In past studies subjects could not tell the difference between the "dirty" air and the clean air. A blood pressure monitoring cuff will be worn the day prior to and after the exposure. One hour prior to each exposure subjects will receive a pre-treatment of either a sugar pill (placebo), Vitamin C 2 g, or a blood pressure medication (Bosentan 500 mg). Patients will return the day after the exposure for a blood draw and a blood vessel function test. There will be a total of 3 study visits. During each visit patients will be exposed to the same air pollution, but will receive a different pre-treatment medication in random order.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACHIEVE P1 - HTN
  • 批准号:
    10494198
  • 项目类别:
  • 资助金额:
    $69.12万
  • 财政年份:
    2021
  • 负责人:
    Robert Daniel Brook
  • 依托单位:
ACHIEVE P1 - HTN
  • 批准号:
    10437396
  • 项目类别:
  • 资助金额:
    $53.78万
  • 财政年份:
    2021
  • 负责人:
    Robert Daniel Brook
  • 依托单位:
ACHIEVE P1 - HTN
  • 批准号:
    10662512
  • 项目类别:
  • 资助金额:
    $57.77万
  • 财政年份:
    2021
  • 负责人:
    Robert Daniel Brook
  • 依托单位:
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
  • 批准号:
    10207776
  • 项目类别:
  • 资助金额:
    $54.12万
  • 财政年份:
    2014
  • 负责人:
    Robert Daniel Brook
  • 依托单位:
国内基金
海外基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
  • 批准号:
    82371144
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    汪雪玲
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
  • 批准号:
    82371465
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李龙宣
  • 依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
  • 批准号:
    82370820
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王天歌
  • 依托单位: